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            Sudden death might complicate the follow-up of symptomatic patients with the Wolff-
Parkinson-White syndrome (WPW) and might be the first event in patients with asymptomatic 
WPW. The risk of sudden death is increased in some clinical situations. Generally, the 
noninvasive   studies   are   unable   to   predict   the   risk   of   sudden   death   correctly   .   The 
electrophysiological study is the best means to detect the risk of sudden death and to evaluate 
the nature of  symptoms. Methods used to define the prognosis of WPW are well-defined. At 
first the maximal rate of conduction through the accessory pathway  is evaluated; programmed 
atrial stimulation using 1 and 2 extrastimuli delivered at different cycle lengths is then used to 
determine the accessory pathway refractory period and to induce a supraventricular tachycardia. 
These methods should be performed in the control state and repeated in adrenergic situations 
either during exercise test or more simply during a perfusion of small doses of isoproterenol. 
The induction of an atrial fibrillation with rapid conduction through the accessory pathway (> 
240/min in control state, > 300/min after isoproterenol) is the sign of a form of WPW at risk of 
sudden   death.                                                                                
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Introduction
            At the time of the curative treatment of Wolff-Parkinson-White syndrome (WPW) by 
radiofrequency ablation,1,2 it is particularly important to detect the forms at risk of sudden death. 
Sudden death in WPW syndrome is related to the degeneration of atrial fibrillation with high 
ventricular rates into ventricular fibrillation.
Natural History Of Wolff-Parkinson-White Syndrome                                   . 
             The exact risk of patients with the WPW syndrome to develop this complication is not 
known. It was relatively high in old studies in symptomatic patients3,4 (1.5%), but was low in 
asymptomatic patients5-7. The most recent study8  reports a sudden cardiac death risk of 
0.02%/patient/year. Previous studies9,10 have shown that ventricular fibrillation can be the first 
event of  the  Wolff-Parkinson-White syndrome.  In  the studies  of  Turner  Montoya9  and 
Timmermans10, ventricular fibrillation was the first manifestation of the WPW syndrome in  
26% and 53% of their series respectively. The risk is low, but these sudden deaths are very 
regrettable; concerning patients with normal hearts except for the WPW, which is easy to cure. 
Therefore, the detection of patients with WPW at risk of sudden death is fundamental. The 
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studies in patients with aborted sudden death indicated that in most of these patients an atrial 
fibrillation with rapid conduction through the accessory pathway is the main finding. How to 
detect   these   patients?                                                                  
Methods   of   Evaluation                                                                          
           The pattern of WPW syndrome on 12 lead surface ECG, the permanent or intermittent 
feature are not specific, although posteroseptal location and permanent forms are more 
frequently   noted   in   patients   at   risk   of   rapid   arrhythmias9,10.                                  
Several   non   invasive   studies   were   proposed   but   their   diagnostic  value   is   low   :
- The abrupt disappearance of WPW syndrome during an exercise stress testing was proposed as 
a sign of accessory pathway with long refractory period11-13; however the abrupt disappearance 
syndrome  is observed rarely, even in patients without risk of severe arrhythmias ; moreover, it 
can   be   noted   in   patients   with   a   short   accessory   period   refractory   period14  as   well.
- Pharmacological tests   were  also proposed : the disappearance of the pattern of WPW 
syndrome was reported as a sign of accessory pathway with long refractory period15; however, 
many   false   positive   tests   were   reported16.                                                      
             Electrophysiologic study appears  to be  the most reliable method to establish the 
prognosis   of   WPW  syndrome17                                                                           
Methods of Electrophysiologic Study in WPW                                                                 
           Patients might be studied by transesophageal route18,19 or intracardiac route. The first 
route is indicated in asymptomatic patients and the second in symptomatic patients to perform 
the catheter ablation of the accessory pathway in a second time ; the advantages of esophageal 
route is that the patient is not hospitalized and is leaving hospital after electrophysiologic study. 
Those with induced atrial arrhythmias are  monitored  until sinus rhythm is restored. It is 
generally   not   necessary   to   hospitalize   these   patients.                                          
           It should be noted that all electrophysiologic studies in WPW syndrome might be 
dangerous and should be performed with an external defibrillator ready to be used, because a 
ventricular fibrillation can be induced in asymptomatic or symptomatic patients 20 (Figure 1). 
 
Figure   1  Direct   induction   of   a   ventricular   fibrillation   by   esophageal   atrial   pacing   at 
progressively increasing  rates in an asymptomatic young man. 
            Surface electrocardiograms and esophageal electrogram are simultaneously recorded on 
paper at speeds of 25 or 100 mm/sec. Cardiac stimulation is performed with a programmable 
stimulator which is connected to a pulse amplifier that can deliver pulses at width of 16 ms with 
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a 29 mA output in the case of esophageal stimulation. For a simple electrophysiological study, 
only one catheter is needed : a bipolar silicone esophageal lead or one bipolar intracardiac 
catheter. A multipolar catheter electrode is  used only for the mapping of left atrium in patients 
who need a catheter ablation of the accessory pathway.                                                       
The   classical   protocol   is   as   follows:                                                                
- Incremental atrial pacing is performed until second degree atrioventricular block occurs. The 
maximal   rate   of   1/1   conduction   trough   the   accessory   should   be   noted.                
- Programmed atrial stimulation at   basic cycle lengths  of 600  ms  and 400 ms with the 
introduction of one and two extrastimuli is performed : the disappearance of WPW syndrome 
indicates the accessory pathway refractory period. The method   is also  used to induce a 
supraventricular   tachycardia,   generally   an   orthodromic   tachycardia,   rarely   an   antidromic 
tachycardia   or   an   atrial   tachycardia   or   fibrillation   .                                              
- These data should be studied under adrenergic situations, except in patients who have a risk of 
sudden death in control state. Two methods are used : atrial pacing might be repeated during an 
exercise testing21,22 which is the most physiological situation, but difficult to perform. Many 
authors prefer the infusion of isoproterenol, a beta-adrenergic drug and which is more simple to 
use during an electrophysiologic study. Isoproterenol (0.02 to 1 µg.min-1) is infused to increase 
the sinus rate to at least 130 beats. min-1 and the pacing protocol is repeated21-23. At the end of 
the protocol, using the following definitions, the prognosis of WPW syndrome can be 
established. These are arrived at using   the electrophysiological characteristics of patients with 
WPW   and   aborted   sudden   death.                                                            
- Sustained atrial fibrillation or reciprocating tachycardia is defined as a tachycardia that is 
longer than 1 minute. The exact duration of induced tachycardia to be considered as pathological 
is still controversed and varies from 30 sec up to 5 minutes  24.                                               
- Conduction over the accessory atrioventricular connection is evaluated by the measurement of 
the shortest atrial cycle length at which there is 1 to 1 conduction over the accessory connection 
and the shortest atrial tachycardia cycle length at which there is 1 to 1 conduction over the 
accessory   connection.                                                                        
- The Wolff-Parkinson-White syndrome is considered as representing a risk of sudden death 
when the following association is observed : sustained atrial fibrillation is induced and the 
shortest RR interval between preexcited beats is < 250 ms in the control state in adults, < 220 
ms in children 25 or < 200 ms during isoproterenol infusion26 (Figure 2).
 
Figure 2 : Rapid conduction through the accessory pathway during atrial pacing (> 300b/min) 
and induction of an atrial fibrillation with very rapid conduction through the accessory pathway 
(300 b/min or cycle length 200 ms) = electrophysiological signs of a form at risk of sudden 
death.
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General   Results   of   Electrophysiological   Studies   in   WPW   Syndrome 
- The exact nature of the prexcitation syndrome is assessed. Most of the WPW syndrome are 
related to a atrioventricular accessory connection or Kent bundle : the degree of prexcitation 
increases during premature atrial stimulation until the refractory period of accessory pathway is 
reached, because the conduction time does not change in accessory pathway with the shortening 
of atrial cycle length while it increases in the AV node. Rarely the WPW syndrome is related to 
a nodoventricular accessory pathway or Mahaim bundle and the degree of preexcitation remains 
unchanged   during   premature   atrial   stimulation.                                                
- The accessory pathway refractory period depends on the driven cycle length. Refractory period 
of   the   accessory   pathway   decreases   as   the   driven   cycle   length   shortens.
- Beta adrenergic stimulation results in shortening of the anterograde refractory period of the 
accessory   pathway   and  an  increase  in  ventricular   rates  during  atrial  pacing  and  atrial 
fibrillation27. Isoproterenol test was also previously used to verify the efficacy of antiarrhythmic 
drug before the era of catheter ablation of accessory pathway. The loss of efficacy of some 
antiarrhythmic drugs was demonstrated after isoproterenol administration28.                    
- Atrial fibrillation is easily induced during intracardiac studies by salvos of rapid atrial 
stimulation and is not specific29. The induction of an atrial fibrillation by intracardiac 
programmed stimulation is obtained in 27 % 21,30, 41 %24 or 56 %28, according to various 
studies in asymptomatic patients and in 75 % of patients with only documented reentrant 
tachycardia24;   atrial   fibrillation  is   induced  in  95  %29  of   those   with  documented  atrial 
fibrillation24. The important variations of the incidence of induced atrial fibrillation depends on 
the technique of programmed stimulation, on the interpretation of the duration of induced 
arrhythmia and on the use of isoproterenol infusion or other means to reproduce the effects of 
adrenergic   stimulation.   In   our   experience,   the   induction   of   an   atrial   fibrillation   during 
transesophageal pacing has a best clinical significance29 : the induction is rarer, from 10 to 30 % 
according to the age in patients without documented atrial fibrillation and remained sensitive to 
induce atrial fibrillation in those with documented atrial fibrillation (95 %). The incidence of 
induction of atrial fibrillation also depends on the presence of an associated heart disease and the 
age of the patient : the induction of atrial fibrillation is rarely noted in children younger than 10 
years, is induced in 20 % of teenagers and adults without heart disease and becomes relatively 
frequent   in   elderly   (31%)31.                                                          
- Ventricular tachyarrhythmias also are easily induced in asymptomatic or symptomatic patients 
by programmed ventricular stimulation and are not specific in patients with WPW syndrome : 
the induction of a ventricular fibrillation is noted in 4 % of WPW syndrome and the induction of 
nonsustained multiform ventricular tachycardia in 37 % of them 32.                                        
- Antidromic tachycardia which is a reciprocating tachycardia using the accessory pathway for 
the anterograde conduction and the normal AV conduction system for retrograde conduction, is 
a rare finding (5%), more frequently noted in young patients with a good retrograde normal VA 
conduction or in patients with several accessory pathways and seems more frequent in patients 
at   risk   of   rapid   arrhythmias.                                                                    
- Orthodromic tachycardia which is a reciprocating tachycardia using the normal AV conduction 
system for the anterograde conduction and the accessory pathway for the retrograde conduction, 
is rarely induced in asymptomatic patients (< 10%)33,34, but represents the most frequent 
tachycardia of symptomatic patients complaining tachycardia and palpitations (90 %)24.      
- The incidence of forms considered at risk of rapid arrhythmias is similar in patients with 
symptomatic and asymptomatic patients and concerns 10 % of the total population with WPW 
syndrome33,34, independent of the age of the patient31 (Figure 3). However the exact clinical 
significance of the electrophysiological form at risk of sudden death in asymptomatic patients 
remains controversial. Previous studies using the intracardiac evaluation of WPW syndrome 
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noted a low incidence of adverse events during a mean follow-up of 4 years35,36. Actually, it is 
no longer possible to evaluate the exact clinical significance of these forms considered at risk of 
sudden death, because of the important development of the techniques of catheter ablation of 
accessory pathway. 
 
Figure   3  :   representation   of   the   data   of   entire   population   according   to   the   age   :
- in black : total number of patients                                                                                                   
- in dark grey : number of induced reciprocating tachycardia                                       
- in light grey : number of induced atrial tachyarrhythmia                                  
- in white : number of dangerous form of WPW syndrome                                    
            Moreover, the presence of syncope does not increase the chance to find a potentially 
dangerous form in adults37; in young patients (< 25 years) the significance of syncope seems 
different and associated with occurrence of atrial fibrillation with a rapid ventricular response 
(sensitivity 64 %, specificity 100 %) 38.                                    
Indications of Electrophysiological Studies in WPW                                                    
- The indications of electrophysiological study are now large in symptomatic patients to perform 
in a second time the catheter ablation of patients complaining frequent sustained tachycardias. 
The study should be performed by catheterisation.                                                             
- In patients with syncope, but no documented tachycardia, electrophysiological study is 
necessary and might be performed by transesophageal route because the role of the accessory 
pathway in the occurrence of syncope remains rare in adults 37.                                  
- In patients who have a documented rapid or syncopal atrial fibrillation, electrophysiological 
study   is   not   indicated,   because   direct   catheter   ablation   of   the   accessory   pathway   is 
recommended. The location of the Kent bundle is easier in sinus rhythm and the induction of an 
atrial   fibrillation   should   be   avoided.                                                          
- In asymptomatic patients, the indications of electrophysiolgical study are more debatable39. At 
first if the study is indicated, esophageal route should be preferred, because the probability to 
find a form at potential risk of sudden death remains rare (10 %). The main interest is to allow 
the patients in 90 % of cases to continue their activities in presence of an electrophysiological 
form without signs of risk of rapid atrial arrhythmias (Figure 4).
 Some   indications   of   a   systematic   electrophysiological   are   actually   recommended   :
1) most of sudden deaths have the peculiarity to occur during exercise40. Because of the 
important development of sports from the infancy to the elderly, it is important to detect those 
patients with WPW at risk of sudden death who practice a sportive activity; the indication 
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generally, begins after 10 years, because the risk of induction of a rapid atrial fibrillation is very 
small and the level of sport still low. In adults only those who practice a sport at a high level (for 
example bicycle) are studied. The competitive athlete should be studied in all ranges of age. The 
indications are also recommended in professions with a high level of sportive activity 
(policemen, soldier, fireman…)
 
Figure 4 : Slow conduction through an accessory pathway and induction by very rapid atrial 
pacing of an atrial fibrillation conducted through the normal AV conduction system = 
electrophysiological signs of a benign WPW syndrome without risk of sudden death.
2) the second indication is the detection of a WPW syndrome in a patient with high 
responsibility   profession   such   as   professional   pilot   (plane,   truck,   bus,   train)
While these indications are largely in teenagers and adults less than 40 years of age, the 
indications   in   children   or   elderly   are   more   controversial:                                    
- in children, the conduction in accessory pathway and normal AV conduction system are more 
rapid, probably without  a clinical significance : in the study of Bromberg25 a cycle length < 220 
ms in basal state is considered at risk of severe arrhythmias in children < 18 years. In adults, the 
value of < 250 ms is taken as a sign of a dangerous form. Moreover, the increase in conduction 
velocity in accessory pathways was reported in children and the disappearance of the Wolff-
Parkinson-White syndrome can be expected, but this is inconstant and not predictible41. 
Therefore, because some sudden deaths as the first event were reported in children25,33, the 
indications should be liberal in children who are competitive athletes and in all children above 
the   age   of   10   years.                                                                          
- in elderly, the shortest atrial pacing cycle length with 1:1 anterograde conduction via the 
bypass tract increased progressively with age42-44. However, the propensity for atrial fibrillation 
was shown to be higher in older patients compared to younger patients45. While the exact 
mechanism is uncertain, degenerative changes associated is the most commonly proposed 
mechanism and the dispersion of atrial refractoriness increases progressively with age45.The risk 
to have a severe arrhythmia as the first manifestation of WPW syndrome in an old patient was 
previously reported46. High level sportive activity is rare in elderly, but other causes for 
adrenergic tone increase might be encountered : for example, an important surgery was the cause 
of the development of a ventricular fibrillation in a 72 year old asymptomatic patient in our 
experience.
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            Therefore, because of the increase of the sport in all ranges of age and particularly in 
young children or after 60 years, the risk of occurrence of a potentially severe arrhythmia in an 
asymptomatic WPW patient should be not underestimated. The reliability and the simplicity of 
transesophageal study in WPW permits easy detection of forms at risk of severe arrhythmia.
            In conclusion, electrophysiological study is the best means to define the prognosis of a 
patient with the WPW syndrome. The study is easily performed by the transesophageal route. 
The indications should be large to avoid the misdiagnosis of a form at risk of rapid arrhythmias. 
This dangerous form is relatively rare in  asymptomatic patients or symptomatic patients with 
unexplained syncope. Most of these patients (>85%) would be allowed to continue their 
activities, without specific treatment, because they have a benign form of Wolff-Parkinson-
White syndrome. In remaining patients, the development of the curative treatment of this disease 
by radiofrequency application on the accessory pathway46 permits to offer the possibility to this 
patient to continue the sport or some professions with stress or exercise. However, if the data of 
electrophysiological study are clear and admitted in all studies, their consequences are still 
debatable : radiofrequency current ablation of asymptomatic patients with the Wolff-Parkinson-
White syndrome is controversial and requires other studies with randomized series comparing 
untreated patients and patients treated by radiofrequency ablation of the accessory pathway.
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